Targeted Molecular Therapies in Oncology: Mechanisms, Resistance, and Emerging Strategies

This chapter surveys the molecular basis and clinical application of targeted anticancer agents, including kinase inhibitors, monoclonal antibodies, and receptor antagonists. It critically evaluates acquired and intrinsic resistance mechanisms and reviews emerging combination strategies and next-generation compounds designed to overcome therapeutic failure in solid and hematological malignancies.